CYBO

CYBO Co., Ltd. (株式会社CYBO) is a Japanese medical technology company headquartered in Koto-ku, Tokyo, focused on digitizing cytology specimens and applying AI to cell analysis. The company was established in July 2018 and operates from the Product Development Support Laboratory of the Tokyo Metropolitan Industrial Technology Research Institute in Aomi, Koto-ku. Its core mission is to "measure cells properly" using high-speed imaging and AI, starting with inspection and diagnostic applications and expanding toward a broad cell-research platform. CYBO's flagship offerings are CYBO Scan and CYBO View. CYBO Scan is an imaging system that captures high-resolution whole-slide 3D images of cytology specimens, acquiring up to 40-layer Z-stacks at high speed and compressing them in real time. It supports an autoloader for 100 glass slides and fits in a compact 50 cm square body with touch-panel operation. CYBO View is a browser-based viewer that decompresses the compressed whole-slide image data in real time, allowing smooth magnification changes, field-of-view navigation, and Z-focus movement without excessive disk usage or long loading times. Together, these products enable remote consultation, conferences, AI research, education, and archiving of valuable specimens. The company also develops CYBO AI Cervix, an AI software that automatically analyzes liquid-based cytology (LBC) specimens from cervical cytology, detecting atypical cells such as LSIL and HSIL with high accuracy. Beyond cervical cancer screening, CYBO is researching platelet activation testing, combining high-speed imaging and AI to explore early biomarkers for atherothrombotic diseases such as cerebral infarction and myocardial infarction. CYBO holds a Second-Class Medical Device Manufacturing and Sales Business license (No. 13B2X10623) and a Medical Device Manufacturing Business registration (No. 13BZ201938). Its business activities include the manufacture and sale of physical and chemical instruments, research software, reagents and consumables, and medical devices; maintenance services; joint research on cell measurement and measurement devices; contracted research and development; and intellectual property management. The company is led by Representative Director Takashi Nitta, with directors Keisuke Goda, Toru Katsumoto, and Yusuke Murata, and auditor Noriyuki Honma. CYBO positions itself at the intersection of digital pathology and AI, aiming to reduce the burden on medical professionals while improving diagnostic accuracy. Its long-term vision is to build a "dictionary of cells" — a big-data infrastructure based on precise measurement of diverse cells — that can contribute not only to medicine but also to basic research, environment, and energy fields.

CYBO Co., Ltd. was established in July 2018 in Tokyo, Japan. The company was founded to address the challenges of digitizing cytology specimens, which had traditionally been difficult to digitize due to their three-dimensional structure, hindering the spread of remote diagnosis and AI utilization. CYBO developed proprietary technology to faithfully digitize cytology specimens and commercialized it as CYBO Scan and CYBO View. These products enable remote consultation, conferences, and AI research. The company has since expanded its focus to AI-based cytology, developing CYBO AI Cervix for automated analysis of cervical LBC specimens, and is researching platelet activation testing for early detection of atherothrombotic diseases. CYBO holds necessary medical device licenses and continues to advance its technology through collaborations and research projects.

• Company established in Tokyo, Japan

• Commentary article on autonomous AI cytology published in 'Experimental Medicine'

• Exhibition at the 24th Annual Meeting of the Japan Digital Pathology and AI Research Group

• Exhibition and lecture at the 40th Kanto Regional Meeting of the Japanese Society of Clinical Cytology

Digital cytology and AI-driven cell analysis for improved diagnostic accuracy and remote consultation.

• CYBO Scan

  High-resolution whole-slide 3D imaging system for cytology specimens, capturing up to 40-layer Z-stacks with real-time compression, autoloader for 100 slides, compact 50 cm body, touch panel operation.

• CYBO View

  Browser-based viewer software for 3D image data captured by CYBO Scan, enabling real-time decompression and smooth navigation, magnification changes, and Z-focus movement.

• CYBO AI Cervix

  AI software that automatically analyzes liquid-based cytology (LBC) specimens from cervical cytology, detecting atypical cells such as LSIL and HSIL with high accuracy.

1. 1細胞データでつくる未来 | 株式会社CYBOcybo.jp
2. 2会社案内 | 株式会社CYBOcybo.jp
3. 3製品 | 株式会社CYBOcybo.jp
4. 4CYBO - Wikidatawikidata.org